Virender Kumar

MedicineBiochemistry, Genetics and Molecular BiologyMaterials Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 19 papers. Top paper: “A Multicenter Phase II Trial of Ruxolitinib for Treatment of Corticosteroid Refractory Sclerotic Chronic Graft-Versus-Host Disease”.

A Multicenter Phase II Trial of Ruxolitinib for Treatment of Corticosteroid Refractory Sclerotic Chronic Graft-Versus-Host Disease

Journal of Clinical Oncology(2024)10.1200/jco.24.00205

N/A

0.545DataRank · unranked

15 citations

Valerie Shostrom, Hannah Choe, Betty K. Hamilton, Krishna Gundabolu, Lori J. Maness +6 more

Nanoformulation design and therapeutic potential of a novel tubulin inhibitor in pancreatic cancer

Journal of Controlled Release(2020)10.1016/j.jconrel.2020.09.052

N/A

0DataRank · unranked

15 citations

Virender Kumar, Svetlana Romanova, Jitender Bariwal, Hao Chen, Shanshan Deng +5 more

Organic Nanocarriers for Delivery and Targeting of Therapeutic Agents for Cancer Treatment

Advanced Therapeutics(2020)10.1002/adtp.201900136

N/A

0DataRank · unranked

43 citations

Jitender Bariwal, Virender Kumar, Chalet Tan, Ram I. Mahato, Yang Peng

Therapeutic targets, novel drugs, and delivery systems for diabetes associated NAFLD and liver fibrosis

Advanced Drug Delivery Reviews(2021)10.1016/j.addr.2021.113888

N/A

0DataRank · unranked

155 citations

Xiaofei Xin, Jingyi Ma, Chalet Tan, Natalia A. Osna, Ram I. Mahato +1 more

Polymeric nanomedicine for overcoming resistance mechanisms in hedgehog and Myc-amplified medulloblastoma

Biomaterials(2021)10.1016/j.biomaterials.2021.121138

N/A

0DataRank · unranked

34 citations

Qiyue Wang, Bharti Sethi, Lin Feng, Vinod Kumar, Donald W. Coulter +3 more

Activation of dsRNA-Dependent Protein Kinase R by miR-378 Sustains Metabolic Inflammation in Hepatic Insulin Resistance

Diabetes(2021)10.2337/db20-0181

N/A

0DataRank · unranked

17 citations

Yongyan Song, Yuxin Wu, Virender Kumar, Ram I. Mahato, Qiaozhu Su +1 more

Diabetes associated fibrosis and drug delivery

Advanced Drug Delivery Reviews(2021)10.1016/j.addr.2021.113968

N/A

0DataRank · unranked

5 citations

Virender Kumar, Ram I. Mahato, Qiaozhu Su

Recent advances in drug delivery and targeting to the brain

Journal of Controlled Release(2022)10.1016/j.jconrel.2022.08.051

N/A

0DataRank · unranked

117 citations

Virender Kumar, Kalika Mahato, Donald W. Coulter, Ram I. Mahato, Bharti Sethi

Nanoparticle Delivery of Novel PDE4B Inhibitor for the Treatment of Alcoholic Liver Disease

Pharmaceutics(2022)10.3390/pharmaceutics14091894

N/A

0DataRank · unranked

18 citations

Virender Kumar, Ram I. Mahato, Jingyi Ma

Anti-miR-96 and Hh pathway inhibitor MDB5 synergistically ameliorate alcohol-associated liver injury in mice

Biomaterials(2023)10.1016/j.biomaterials.2023.122049

N/A

0DataRank · unranked

29 citations

Bharti Sethi, Dalton W. Staller, Xiaofei Xin, Jingyi Ma, Yuxiang Dong +3 more

Targeting BRD4 and PI3K signaling pathways for the treatment of medulloblastoma

Journal of Controlled Release(2023)10.1016/j.jconrel.2022.12.055

N/A

0DataRank · unranked

16 citations

Virender Kumar, Thilina D. Jayasinghe, Yuxiang Dong, Donald R. Ronning, Haizhen A. Zhong +3 more

Natural killer cells for pancreatic cancer immunotherapy: Role of nanoparticles

Cancer Letters(2023)10.1016/j.canlet.2023.216462

N/A

0DataRank · unranked

8 citations

Ram I. Mahato, Virender Kumar

Gemcitabine elaidate and ONC201 combination therapy inhibits pancreatic cancer in a KRAS mutated syngeneic mouse model

Research Square(2023)10.21203/rs.3.rs-3108907/v1

N/A

0DataRank · unranked

2 citations

Virender Kumar, Bhartu Sethi, Dalton W. Staller, Ram I. Mahato

Anti-CLL1 liposome loaded with miR-497-5p and venetoclax as a novel therapeutic strategy in acute myeloid leukemia

Molecular Therapy(2024)10.1016/j.ymthe.2024.09.036

N/A

0DataRank · unranked

13 citations

Xiaofei Xin, Sohan Mahto, Yuxiang Dong, Virender Kumar, R. Katherine Hyde +4 more

Gemcitabine elaidate and ONC201 combination therapy for inhibiting pancreatic cancer in a KRAS mutated syngeneic mouse model

Cell Death Discovery(2024)10.1038/s41420-024-01920-9

N/A

0DataRank · unranked

14 citations

Bharti Sethi, Dalton W. Staller, Prakash Shrestha, Ram I. Mahato, Virender Kumar

A novel phosphodiesterase inhibitor for the treatment of chronic liver injury and metabolic diseases

Hepatology(2024)10.1097/hep.0000000000000999

N/A

0DataRank · unranked

9 citations

Sanjali S. Panigrahi, Yahani P. Jayasinghe, Yuxiang Dong, Sohan Mahto, Virender Kumar +3 more

Drug delivery and targeting to chemoresistant pancreatic cancer

Cancer Letters(2024)10.1016/j.canlet.2024.216648

N/A

0DataRank · unranked

0 citations

Ram I. Mahato, Virender Kumar

Redox-responsive nanoplatform for codelivery of miR-519c and gemcitabine for pancreatic cancer therapy

Science Advances(2020)10.1126/sciadv.abd6764

N/A

0DataRank · unranked

80 citations

Virender Kumar, Feng Lin, Vinod Kumar, Rajan Sharma Bhattarai, Vijaya Raj Bhatt +3 more

Lipid nanomedicine simultaneously inhibits BRD4/PI3K and MDM2/XIAP signaling pathways for effective treatment of Medulloblastoma

Journal of Controlled Release(2025)10.1016/j.jconrel.2025.114266

N/A

0DataRank · unranked

1 citations

Aditya K. Gupta, Qiaoyu Pan, Sohan Mahto, Ajaykumar Chittipolu, Helen Erickson +9 more